Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study.
about
Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Risk-stratified therapy for ch ...... s from the JPLSG AML-05 study.
@en
Risk-stratified therapy for ch ...... s from the JPLSG AML-05 study.
@nl
type
label
Risk-stratified therapy for ch ...... s from the JPLSG AML-05 study.
@en
Risk-stratified therapy for ch ...... s from the JPLSG AML-05 study.
@nl
prefLabel
Risk-stratified therapy for ch ...... s from the JPLSG AML-05 study.
@en
Risk-stratified therapy for ch ...... s from the JPLSG AML-05 study.
@nl
P2093
P2860
P1476
Risk-stratified therapy for ch ...... ts from the JPLSG AML-05 study
@en
P2093
Akiko Moriya Saito
Akitoshi Kinoshita
Daisuke Tomizawa
Hideki Nakayama
Hiroaki Goto
Hiroshi Moritake
Hiroyuki Takahashi
Katsuyoshi Koh
Keizo Horibe
P2860
P2888
P304
P356
10.1007/S12185-017-2395-X
P577
2018-01-12T00:00:00Z